Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-05-10
2011-05-10
Li, Q. Janice (Department: 1633)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S005000, C435S006120
Reexamination Certificate
active
07939271
ABSTRACT:
The present invention relates to prostate cancer markers, compositions comprising such markers, immunoglobulins specific for such markers, and methods of using such markers and/or immunoglobulins to assess an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer.
REFERENCES:
patent: 5637483 (1997-06-01), Dranoff
patent: 5904920 (1999-05-01), Dranoff
patent: 5985290 (1999-11-01), Jaffee
patent: 6033674 (2000-03-01), Jaffee
patent: 6277368 (2001-08-01), Hiserodt
patent: 6350445 (2002-02-01), Jaffee
patent: 6464973 (2002-10-01), Levitsky
patent: 7339089 (2008-03-01), Gotoh
patent: 7666985 (2010-02-01), Sugiyama et al.
patent: 2006/0057127 (2006-03-01), Liu et al.
patent: WO00/26676 (2000-05-01), None
patent: WO00/72686 (2000-12-01), None
Hege et al. Intl Rev Immunol 2006;25:321-52.
Ogata et al. Prostate 2004;60:273-81.
Abe et al., Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction. J. Canc. Res. Clin. Oncol. 121: 587-592 (1995).
Adams, M.D., Kerlavage, A.R., Fleischmann, R.D., Fuldner, R.A., Bult, C.J., Lee, N.H., Kirkness, E.F., Weinstock, K.G., Gocayne, J.D., White, O. et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 377 (6547 SUPPL), 3-174 (1995).
Altschul et al., Basic Local Alignment Search Tool. J. Mol. Biol. 215: 403-410 (1990).
An, S., Cho, K.H., Lee, W.S., Lee, J.O., Paik, Y.K. and Jeong, T.S. A critical role for the histidine residues in the catalytic function of acyl-CoA: cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2. Lett. 580 (11), 2741-2749 (2006) PMID 16647063.
Aoki et al., Expression of marine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo. Proc Natl Acad Sci USA. 89(9):3850-4, 1992.
Armstrong T. D. and Jaffee E. M., Cytokine modified tumor vaccines. Surg Oncol Clin N Am. 11(3):681-96, 2002.
Asano, K., Kinzy, T.G., Merrick W.C. and Hershey, J.W. Conservation and diversity of eukaryotic translation initiation factor eIF3, J. Biol. Chem. 272 (2), 1101-1109 (1997). PMID 8995409.
Balakirev, M.Y., Tchemiuk, S.O., Jaquinod, M. and Chroboczek, J. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep. 4 (5), 517-522 (2003).
Bartee, E., Mansouri, M., Hovey Nerenberg, B.T., Gouveia, K. and Fruh, K. Downregulation of major histocompatibility complex class 1 by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78 (3), 1109-1120 (2004) PMID 14722266.
Batzer et al., Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus. Nucleic Acid Res. 19: 5081 (1991).
Bell, S.P., Learned, R.M., Jantzen, H.M. and Tjian, R. Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis. Science 241 (4870), 1192-1197 (1988) PMID 3413483.
Bennett, M.J., Hosking G.P., Smith, M.F., Gray. R.G. and Middleton, B. Biochemical investigations on a patient with a defect in cytosolic acetoacetyl-CoA thiolase, associated with mental retardation. J. Inherit. Metab. Dis. 7(3), 125-128 (1984) PMID 6150136.
Bilbe, G., Delabie, J., Bruggen, J., Richener, H., Asselbergs, F.A., Cerletti, N., Sorg, C., Odink, K., Tarcsay, L., Wiesendanger, W. et al. Restin: a novel intermediate filament-associated protein highly expressed in the Reed-Sternberg cells of Hodgkin's disease. EMBO J. 11 (6), 2103-2113 (1992) PMID 1600942.
Bodey, B. et al., Failure of Cancer Vaccines: The Significant Limitations of this Approach to Immunotherapy. Anticancer Res 20(4):2665-76, 2000.
Bomont, P., Maddox, P., Shah, J.V., Desai, A.B. and Cleveland, D.W. Unstable microtubule capture at kinetochores depleted of the centromere-associated protein CENP-F, EMBO J. 24 (22), 3927-3939 (2005) PMID 16252009.
Boon and Old, Cancer Tumor Antigens. Curr Opin Immunol. Oct. 1, 1997; 9(5):681-683.
Borello and Pardoll, GM-CSF-based cellular vaccines: a review of the clinical experience, Growth Factor Rev. 13(2):185-93, 2002.
Bradford, T.J., Wang, X., Chinnaiyan, A.M. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer. Urol Oncol. May-Jun. 2006;24(3):237-42 PMID 16678056.
Bruderer, R.M., Brasseur, C., Meyer, H.H. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Np14 and p47, through a common bipartite binding mechanism. J Biol Chem. Nov. 26, 2004; 279(48):49609-16. Epub Sep. 15, 2004 PMID 15371428.
Burstein, E., Hoberg, J.E., Wilkinson, A.S., Rumble, J.M., Csomos, R.A., Komarck, C.M., Maine, G.N., Wilkinson, J.C., Mayo, M.W., Duckett, C.S., COMMD proteins, a novel family of structural and functional homologs of MURR1, J. Biol. Chem. 280 (23), 22222-22232 (2005).
Cantrell et al., Cloning, sequence, and expression of a human granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci., 82, 6250-6254, 1985.
Cárcamo, C., Pardo, E., Oyanadel, C., Bravo-Zehnder, M., Bull, P., Caceres, M., Martinez, J., Massardo, L., Jacobelli, S., Gonzalez, A, Soza, A. Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells. Exp. Cell Res. 312 (4), 374-386 (2006).
Carlsson, S., Oberg, C.T., Carlsson, M.C., Sundin, A., Nilsson, U.J., Smith, D., Cummings, R.D., Almkvist, J., Karlsson, A. and Leffler, H. Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology 17 (6), 663-676 (2007).
Casiano, C.A., Mediavilla-Varela, M. Tan, E.M. Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics. Oct. 2006;5(10):1745-59. Epub May 29, 2006 PMID 16733262.
Cha, H., Dangi, S., Machamer, C.E. and Shapiro, P. Inhibition of mixed-lineage kinase (MLK) activity during G2-phase disrupts microtubule formation and mitotic progression in HeLa cells, Cell. Signal. 18 (1), 93-104 (2006).
Chadee, D.N. and Kyriakis, J.M. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nat. Cell Biol. 6 (8), 770-776 (2004) PMID 15258589.
Chang A et al., Immunogenetic Therapy of Human Melanoma Utilizing Autologous Tumor Cells Transduced to Secrete Granulocyte-Macrophage Colony-Stimulating Factor. Human Gene Therapy 11:839-850, 2000.
Chaudhuri, J., Chakrabarti and Maitra, U. Biochemical characterization of mammalian translation initiation factor 3 (eIF3). Molecular cloning reveals that p110 subunit is the mammalian homologue orSarcharomyces cerevisiaeprotein Prtl. J. Biol. Chem. 272 (49), 30975-30983 (1997) PMID 9388245.
Chen, H., Chedotal, A., He, Z., Goodman, C.S. and Tessier-Lavigne, M, Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III, Neuron 19 (3), 547-559 (1997).
Chen, H., He, Z., Bagri, A. and Tessier-Lavigne, M., Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins, Neuron 21 (6), 1283-1290 (1998).
Chen, Y., Sharp, Z.D. and Lee, W.H. HEC binds to the seventh regulatory subunit of the 26 S proteasome and modulates the proteolysis of mitotic cyclins J. Biol. Chem. 272 (38), 24081-24087 (1997) PMID 9295362.
Ciferri, C., De Luca, J., Monzani, S., Ferrari, K.J., Ristic, D., Wyman, C., Stark, H., Kilmartin, J., Salmon, E.D. and Musacchio, A. Architecture of the human ridc80-hec 1 complex, a critical constituent of the outer kinetochore J. Biol. Chem. 280 (32), 29088-29095 (2005) PMID: 15961401.
Ciszak, E.M., Makal, A., Hong, Y.S., Vettaikkorumakankauv, A.K., Korotchkina, L.G. and Patel, M.S., How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydr
Harding Thomas
Jooss Karin
Koprivnikar Kathryn E.
Nguyen Minh
BioSante Pharmaceuticals, Inc.
Jones Day
Li Q. Janice
LandOfFree
Methods and compositions for identifying prostate cancer or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for identifying prostate cancer or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for identifying prostate cancer or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2640412